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Abstract
Background: Malta has one of the lowest reported 
incidence rates of tuberculosis in Western Europe, and was 
approaching the elimination phase. It was observed that a 
disproportionate number of cases were occurring among 
persons of advanced age.
Objective:  To investigate the epidemiology of tuberculosis 
in the elderly Malta-born population.
Methods: A retrospective review of national TB surveillance 
data from 1995 to 2005 with estimation of 11-year means. Age 
stratified comparisons between the general, the younger, and 
the elderly Malta-born populations were made. 
Results: One hundred and seventeen Malta-born patients 
were included in the study; 99% of all notified cases. The mean 
stratified incidence rates of TB among the general population, 
those less than 65 years of age, and the elderly (65 years 
and over) were 2.8, 1.6, and 10.6 per 100,000 person-years 
respectively. When the study sample was stratified into 15-year 
age groups, their mean TB incidence showed an exponential 
increase. All major age groups showed a fall in incidence, with 
the elderly group featuring the steepest decline of about 5% 
per year. The stratified incidence ratio of males to females, and 
pulmonary to extra-pulmonary TB was greatest in the elderly. 
Relapse occurred more commonly amongst elderly males. 
Conclusion: Contrasting age-stratified differences in 
incidence, gender, site, relapse, and mortality rates were 
discovered between the two major age groups, with the 
elderly forming a sub-population with distinct TB-related 
characteristics. Thus, the elderly, even when living in very low 
TB-incidence regions, should receive particular consideration.
Introduction
Tuberculosis (TB) in Western Europe is characterised by an 
overall reduction in incidence rates in past years.1,2,3 If persons 
with HIV/AIDS are excluded, the elderly native population 
in these countries can be considered to be a high-risk group 
for developing TB.4 These countries have also experienced 
an increase in their elderly population, with an increase in 
both absolute and relative numbers.5 The Maltese islands are 
considered to be a low TB-incidence country,2,3 and while an 
increasing number of cases appear to be occurring among 
the elderly, no recent detailed epidemiological studies had 
investigated this phenomenon. The aim of this study is to 
describe the epidemiology of TB amongst the Malta-born elderly 
living in Malta; a very low TB incidence country.
Methods
  A study period of eleven years, from 1995 to 2005 (both 
years included), was chosen. This period provided data which 
was reliable. The sample consisted of 117 new and 6 relapse 
cases, which is more than 99% of those notified during this 
period. The study sample included only those persons who 
were Malta-born and excluded foreign-born persons in order 
to obtain an unbiased picture of TB epidemiology in the native 
population. All new `definite` and `other than definite` cases 
diagnosed Malta-born population were included. Tuberculosis 
diagnosed in the elderly, was compared to that occurring among 
the general population and to those aged less than 65 years. Age 
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stratified comparisons regarding incidence, gender, site, and 
mortality were made. 
All denominator populations were obtained from the official 
published Demographic Reviews of the National Statistics Office 
of Malta. The population of each year studied is the end of 
year Malta-born population.5 All case data were collected from 
the Chest Clinic and Chest Unit, which co-operate to ensure 
complete surveillance in Malta.
Eleven-year population averages and incidence rates were 
calculated, in order to smooth out trend instability due mainly 
to low case and population numbers. One case was excluded 
because of incomplete data. 
Pulmonary TB is defined as disease involving the lung 
parenchyma, tracheo-bronchial tree and larynx, even when other 
sites are simultaneously involved. All TB disease involving other 
sites in isolation, are considered as extra-pulmonary.3 New cases 
were those treated for the first time with standard short-course 
chemotherapy. A low TB incidence country is defined as one with 
a rate of less than 20 per 100,000 person years. This study’s 
definition of ‘very low incidence area’ is a country or area with 
an incidence of 5 or less per 100,000 person-years for three 
consecutive years. The elimination phase is reached when the 
incidence of all forms of active TB falls below 1 case per million 
population per year.1 The elderly were defined as persons with 
an age of 65 years and over, while those assigned to the younger 
age group were less than 65 years of age.
Diagnosing physicians are required by law to notify all forms 
of TB. All patients, apart from those with HIV/AIDS, are treated 
and followed-up by the Chest Clinic, including those few patients 
who were diagnosed privately. Anti-TB medication cannot be 
obtained commercially, and the Chest Clinic is notified monthly 
of dispensation of such medication by state pharmacies. Free-
of-charge anti-TB drugs can only prescribed by designated 
senior physicians, and can only be dispensed by two particular 
state pharmacies. Patients’ files were checked to confirm that 
bacteriological, histological, and/or other clinical evidence 
supported the diagnosis. TB cases included were those with a 
definite (bacteriologically confirmed) and ‘other than definite’ 
(histological, radiological and/or clinically confirmed) diagnosis, 
and were treated with standard short-course chemotherapy. 
It is laboratory policy to examine all samples obtained from 
suspected TB patients with the Ziehl–Neelsen stain and to 
culture on Lowenstein-Jensen medium for acid-fast bacilli 
(AFB). All cultures positive for AFB were referred for species 
identification and drug sensitivity testing to a national reference 
laboratory in the United Kingdom. DNA fingerprinting of 
positive cultures was not performed during the study period. 
  
Results
Incidence: The mean Malta-born population for the 11-
year study period was estimated at about 382,000. A total of 
117 persons developed TB and were treated for the first time. 
The population was further sub-divided into a younger age 
group with a mean population of around 335,000; 62 of whom 
developed TB, and an elderly population of around 47,000; 55 
of whom developed TB (Table 1). The mean yearly incidence 
over eleven years for new cases of TB among the general, the 
younger, and the elderly population was 2.8, 1.6, and 10.6 per 
100,000 person-years respectively. 
The new Malta-born TB cases were also stratified according 
to age into one of six 15-year age categories. The mean yearly 
incidence over the 11 year was calculated for each of these 
six categories (Figure 1). The incidence of TB rises nearly 
exponentially with the increasing age of these groups. The 
greatest incidence amongst them was seen in the 75 to 90 age 
group, with an incidence of 14.9 per 100,000 person-years. 
There were only a few cases in the 0 to 15 year category; this 
was the lowest incidence rate at 0.8 per 100,000 person- years, 
also, between 2000 and 2005, no new cases were diagnosed 
among this group.
The TB incidence for each individual year of the study period, 
for both young and elderly, show a decreasing trend of 2.5, and 
5% per year respectively (Figure 2). 
Gender ratio: In total, there were 81 (69%) male and 36 
(31%) female cases of TB. The mean stratified incidence among 
males and females was 3.9 and 1.7 per 100,000 person-years 
respectively (Table 1) with a male to female incidence ratio of 
2.3 to 1, a ratio very similar to that found among populations 
of Western Europe.3
Among the younger group, there were 41 (66%) male and 
21 (34%) female cases of TB. The male and female stratified 
incidence was 2.2 and 1.2 per 100,000 person-years respectively, 
and the male to female incidence ratio in this younger group was 
the smallest at 1.8 to 1 (Figure 3 and Table 1).
Among the elderly, there were 40 (73%) male and 15 (27%) 
female TB cases. The incidence among elderly males and 
females was 18.3 and 5 per 100,000 person-years respectively; 
the incidence ratio, in this group, was the highest at 3.7 to 1 
(Figure 3 and Table 2).
Site:  There were 96 (82%) cases of pulmonary TB, making 
this the commonest site of infection. The second commonest site 
involved lymph nodes in 9 cases. There were 21 (18%) cases of 
extra-pulmonary TB, involving a variety of other sites (Table 2). 
Figure 1: Mean incidence for 15-year age categories in 
those Malta-born for the years 1995-2005
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developed TB, and an elderly population of around 47,000; 55 
of whom developed TB (Table 1). The mean yearly incidence 
over eleven years for new cases of TB among the general, the 
younger, and the elderly population was 2.8, 1.6, and 10.6 per 
100,000 person-years respectively. 
The new Malta-born TB cases were also stratified according 
to age into one of six 15-year age categories. The mean yearly 
incidence over the 11 year was calculated for each of these 
six categories (Figure 1). The incidence of TB rises nearly 
exponentially with the increasing age of these groups. The 
greatest incidence amongst them was seen in the 75 to 90 age 
group, with an incidence of 14.9 per 100,000 person-years. 
There were only a few cases in the 0 to 15 year category; this 
was the lowest incidence rate at 0.8 per 100,000 person- years, 
also, between 2000 and 2005, no new cases were diagnosed 
among this group.
The TB incidence for each individual year of the study period, 
for both young and elderly, show a decreasing trend of 2.5, and 
5% per year respectively (Figure 2). 
Gender ratio: In total, there were 81 (69%) male and 36 
(31%) female cases of TB. The mean stratified incidence among 
males and females was 3.9 and 1.7 per 100,000 person-years 
respectively (Table 1) with a male to female incidence ratio of 
2.3 to 1, a ratio very similar to that found among populations 
of Western Europe.3
Among the younger group, there were 41 (66%) male and 
21 (34%) female cases of TB. The male and female stratified 
incidence was 2.2 and 1.2 per 100,000 person-years respectively, 
and the male to female incidence ratio in this younger group was 
the smallest at 1.8 to 1 (Figure 3 and Table 1).
Among the elderly, there were 40 (73%) male and 15 (27%) 
female TB cases. The incidence among elderly males and 
females was 18.3 and 5 per 100,000 person-years respectively; 
the incidence ratio, in this group, was the highest at 3.7 to 1 
(Figure 3 and Table 2).
Site:  There were 96 (82%) cases of pulmonary TB, making 
this the commonest site of infection. The second commonest site 
involved lymph nodes in 9 cases. There were 21 (18%) cases of 
extra-pulmonary TB, involving a variety of other sites (Table 2). 
The denominator populations, number of pulmonary and extra-
pulmonary cases, their age stratified incidence, and incidence 
ratios according to major age groups is shown in Table 1.
Drug resistance: Mycobacterium tuberculosis complex 
was cultured in 38 (41.3%) patients with pulmonary TB. Drug 
resistance was discovered in only one new case; an elderly 
male and former dairy farmer, who had Mycobacterium bovis 
infection. This was expected as M. bovis is naturally resistant 
to pyrazinamide.
HIV/AIDS: Among new and relapsing cases, none of those 
tested were positive for HIV. 
Treatment outcome: In the period studied, out of the 117 new 
cases treated, 106 (90%) were treated successfully, and 11 died 
before completing treatment (Table 2). There were no patients 
allocated to the other treatment outcome categories.
Relapses: There were 123 Malta-born TB cases, which 
included 117 (95 %) new and 6 (5%) relapse cases. None of the 
relapses were considered as re-infection. In the elderly group, 
of the 5 males who had relapsed, one eventually died during 
treatment. There was only one other relapse who had been 
originally diagnosed and treated as a new case during the study 
period. There was only one female, from among the younger 
group, who had relapsed. The relapse rates among the general, 
younger, and elderly age groups were 1.6, 0.3, and 10.6, per 
100,000 person-years respectively. 
Mortality: Malta’s mortality rate was 0.26 per 100,000 
person years. The percentage of deaths among TB cases in the 
general population, the younger group, and elderly was 9.4, 4.9, 
and 14.3% respectively.
Figure 3: Incidence of TB by age and gender in those 
Malta-born for the years 1995-2005
Table 1: Age stratified Malta-born data for the years 1995-2005. Mean population, cases, mean incidence, pulmonary and 
extra-pulmonary cases, incidence and mortality rates
Major age group Malta-born population Population < 65 years Population ≥ 65 years
Mean population 382,393 335,021 47,374
New TB cases 117 62 55
Mean yearly incidence 2.8 1.6 10.6
Pulmonary TB cases 96 47 49
Mean pulmonary TB incidence 2.3 1.3 9.4
Extra-pulmonary TB cases during the study
per 100,000 person years 21 14 7
Extra-pulmonary TB per 100,000 person years 0.5 0.38 1.3
Pulmonary to extra-pulmonary TB incidence ratio 4.6 to 1 3.4 to 1 7.2 to 1
Patients who relapsed over 11 years 6 1 5
Mean relapse rate per 100,000 person-years 0.14 - 1
Number of deaths over 11 years  11 3 8
% deaths among TB cases 9.4% 4.9% 14.3%
Mean mortality rate per 100,000 person-years 0.14 0.08 1.5
Figure 2: Incidence of TB in major age groups in those 
Malta-born for individual years (1995-2005)
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Discussion 
Incidence: With a TB incidence of 4 times the national 
average, and 7 times that in the younger group, the elderly can 
be considered a high-risk group for TB among the Malta-born 
population. These findings are consistent with those obtained 
in other European populations.2,3,4 
In addition, over the 11 years studied, the mean incidence 
of TB rises nearly exponentially with 15-year age segments 
(Figure.1); a similar finding also observed among most 
populations in the EU when 2006 alone was considered.3 
Elderly persons are considered to have an increased risk 
of developing tuberculosis due to reactivation of latent TB 
infection, occurring as a result of age-related changes in cell-
mediated immunity.8 An impaired immune system resulting 
from conditions such as HIV/AIDS,9 diabetes, long-term steroid 
use, malnutrition, malignancy, lung fibrosis, silicosis9 and 
smoking,10 in combination with a higher incidence of latent TB 
infection acquired in youth, may lead to an increased risk of 
tuberculosis later on in life.1 
While the incidence has fallen across all age groups; the 
elderly have shown the greatest trend reduction at 5 % per year. 
In comparison, the drop among those below 65 years of age was 
2.5 % per year, which finding is consonant with trends in Ireland, 
Italy, Norway and other countries where the incidence is also 
falling among the elderly.3 In the European Union, considering 
the two periods of 1998 to 2002, and 2002 to 2006, the fall 
in TB incidence in the general population was 1.3% and 4% 
respectively.3 These figures must be interpreted in the light 
of the significant enlargement of European Union. The above 
average fall in incidence among the Maltese elderly, may be the 
result of an effective National Tuberculosis Programme (NTP), 
and improvement of the socio-economic environment. Delayed 
patient referral, delayed and missed diagnosis, may lead to an 
under-estimation of TB among the elderly and a surreptitious 
fall in TB incidence.3 These factors may also hamper control 
measures, and contact screening, resulting in a longer period 
of infectiousness and transmission. There were no notifications 
of elderly patients with TB during 2003. This could also be due 
to delayed notification, and the fact that no cases arose in that 
particular year as a result of year-to-year case fluctuations in a 
very low incidence country with a small population. Meanwhile, 
when incidence of tuberculosis is very low, a larger proportion 
of positive sputum smears are due to a relative increase of 
environmental mycobacterial infections, this usually occuring 
among elderly persons who were heavy smokers and/or have 
chronic respiratory disease. This can result in a false positive 
diagnosis being made if cultures are not grown. 
A significant indicator of ongoing TB infection within a 
population is the incidence of TB in the 0-14 year old age group 
(Figure 1); this because young children (especially those from 0 
to 5 years) are highly susceptible to TB infection and disease.3
The ultimate aim of all National TB Programmes is the 
elimination of TB in a country. It would appear that accurate 
and timely monitoring of stratified incidence, as the elimination 
phase is being approached, can give a clearer picture of the 
success or failure of tuberculosis control. This can indicate when 
and where specific interventions are warranted; interventions 
may include discontinuing routine vaccination programmes, 
screening of high-risk groups for infection and disease, and 
treatment of latent infection in these groups. Surveillance 
has always been one of the pillars of the Direct Observed 
Treatment Strategy (DOTS) as promulgated by the World Health 
Organization.8
Gender ratio: The difference in incidence, as regards 
gender, occurs in most countries,11 and the situation in Malta 
is consonant with this recognised phenomenon, even when 
one takes into consideration the islands’ small population, 
geographic isolation, relatively high socio-economic standards 
and free and easy access to all state health services. This marked 
difference between genders, not only exists among the general 
population, but was also found among younger and elderly age 
groups. The difference in gender incidence ratio, among the 
elderly, was found to be nearly double that found among the 
younger group. Explanations that may be considered include, 
differential exposure to smoking and airborne pollutants, 
differences in person-to-person interaction, work practices, 
and genetic differences.
Site: Pulmonary TB is much commoner than extra-
pulmonary TB among the general population: a finding common 
to both elder and younger age groups. In Western Europe, 
80% of cases in the general population are pulmonary in site.3 
In Malta this proportion is 82% (Table 2). The pulmonary to 
extra-pulmonary TB incidence ratio in Malta was found to be 
twice as high among the elderly than in the young, with elderly 
males having the highest ratio (Table 2). 
Drug Resistance: Drug resistance was not discovered among 
new or relapsed cases, thus reflecting favourably on the NTP. 
This sensitivity profile is clinically helpful in the empirical choice 
of initial anti-TB drug regimes in the Malta-born population. 
The NTP’s DOT policy together with long-term nationwide socio-
economic improvement has lead to a reduction in TB incidence, 
and also kept drug resistance in abeyance.
Table 2: New TB; case number and rate according to site 
in those Malta-born for years 1995 to 2005
Major site  Cases Major site New cases
Pulmonary (82 %) 96 pulmonary 96
Extra-Pulmonary (18 %) 21 lymph node 9
  pleural 2
  meninges 2
  skin 2
  urinary tract 2
  Digestive tract 1
  epididymis 1
  endometrium 1
  bone 1
Total 117  117
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HIV/AIDS: None of the cases discovered were found to be 
co-infected with HIV. Routine HIV testing on TB cases, was 
started from 2000; prior to this year all were offered screening 
but only those considered as having any increased risk of 
HIV/AIDS were strongly advised to undergo testing. During 
the period from 2000 to 2005, of the 63 new and relapse TB 
patients, 53 (85%) were screened for HIV, and none were 
found to be positive, whilst 15% had declined testing. There 
is no reason to believe that the incidence of HIV/AIDS in TB 
patients, including the elderly, will not follow trends similar to 
that found in other countries.5 
Treatment outcome:  Malta has exceeded the minimum 85% 
successful treatment outcome as recommended by WHO: even 
among the elderly group with the highest mortality rate.
Relapses: While the number of cases who relapsed was 
small, the elderly’s tendency to relapse was observed to be much 
higher (35 times) to relapse than the younger group. Relapse 
occurred more commonly among the elderly: especially males, 
and was not found to be associated with reduced compliance, 
drug resistance, HIV/AIDS, or re-infection. One explanation 
may include the re-activation, of previously well treated disease, 
in a person with a progressively impaired immune system, 
occurring with age, and/or other co-morbidities. No DNA 
fingerprinting studies were carried out during the study. No drug 
resistance was discovered among cases who relapsed. 
Mortality: The mortality in the EU for the period 2001-2006 
was 0.7 and found to vary from 0 and 9.6 per 100,000 person-
years.3 Malta’s rate compares favourably at 0.26 per 100,000 
person-years. During the study period, the mortality rate among 
the elderly was nearly 6 times greater than the mortality rate 
among the general population, and nearly 19 times greater when 
compared to the younger group.
Study limitations:  The epidemiology of tuberculosis in 
those who were foreign-born was not taken into account for 
this study but this was accepted to obtain a clearer picture of 
TB among those who were Malta-born. Eleven years mean data 
were analysed in most cases as single year data were considered 
too small to be reliable. While the number of new Malta-born 
TB cases over eleven years was small (117) it was comprehensive 
as 99% of cases were included. The cases studied included 
both definite, and other than definite cases, therefore clinical, 
radiological, and histological over-diagnosis may have occurred. 
DNA fingerprinting was not performed prior to 2006; thus the 
possibility of cross-contamination of samples, which is known 
to occur universally, could not be excluded.
Conclusions 
The study supports the initial observation that tuberculosis 
was occurring more often in the Malta-born elderly. This group 
as a whole, elderly males and the very old (75 to 85 years) are 
specific high-risk groups for TB, when compared to the general 
and younger populations. Very low incidence of TB among 
children (0-15 years) was discovered; this is a good indicator that 
on-going TB infection among the native community was low. The 
findings of both low and falling trends in TB incidence among 
all age groups indicate the success of long-standing measures 
taken to control TB among the native population. The marked 
age-related differences discovered in gender, incidence, site, and 
mortality should continue to alert physicians, and public health 
specialists that the elderly form a sub-population with distinct 
TB-related characteristics, even when the population studied is 
small, the incidence of TB is very low and when the elimination 
phase is being approached.
Recommendations
1. Particular attention should be given to the challenge of 
tuberculosis amongst the elderly sub-group.
2. Increasing awareness among the population and 
health-care staff to reduce unnecessary delay in referral, 
investigation, diagnosis, and treatment of TB. The 
possibility of both under and over diagnosis should always 
be considered.
3. Treatment of latent TB among the elderly, especially those 
with radiological evidence of fibrotic changes compatible 
with old pulmonary TB, may be one way to further reduce 
reactivation of tuberculosis, and should be considered.1,6,7,8 
4. To investigate whether the discontinuation of the routine 
school BCG vaccination programme, due to very low 
incidence of TB, is indicated. 
5. As all foreign-born TB patients were excluded, their impact 
on the health-care services, and on the local population 
should be investigated. The foreign-born populations` own 
particular epidemiology should be the subject of future 
studies. 
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